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Aims  
 
Human lung diseases are among the most important causes of morbidity and 
mortality in the world.  Chronic obstructive pulmonary disease (COPD), lung fibrosis 
and emphysema - either without a known cause or secondary to other diseases such 
as infections or autoimmune disorders – are examples of devastating and life 
threatening conditions for which effective treatments are still lacking.  Even when 
sometimes the cause is obvious (e.g. cigarette smoking...), many aspects of the 
pathophysiology of lung diseases remain to be understood in order to find targets for 
effective treatment.  To unravel disease processes in the lung and to develop new 
therapeutic strategies in a preclinical setting, animal models (e.g. rat, mouse, 
ferret…) are indispensable and widely used [1].  In these animals, the resulting lung 
pathology is routinely quantified by labor-intensive end-stage histological 
assessments that require many animals.  Although histological techniques will remain 
essential to unravel pathogenesis at a molecular and cellular level, they lack the 
ability to provide dynamic information on disease progression and potential 
therapeutic effects. As the course of disease progression and potential response to 
therapy in rodent models shows substantial inter-individual variation, non-invasive 
techniques are indispensable to dynamically monitor disease development and 
progression to establish the kinetics of pathogenic events or treatment effects for 
each animal individually.  At present, imaging tools for the evaluation of lung disease 
with good temporal and spatial resolution in vivo are limited.  µCT has proven to be 
an efficient and safe non-invasive method to provide dynamic information on lung 
fibrosis and emphysema progression in mice [2].  However, to extend µCT scanning 
protocols to animal models that require more frequent scanning or over longer 
periods of time (e.g. in transgenic mouse models with slow and/or unpredictable 
disease onset), radiotoxicity issues that could interfere with the µCT read-out for the 
lung must be considered.  As radiation-induced lung fibrosis is an important 
manifestation of radiotoxic damage, this is a particularly relevant potential 
confounding factor when using µCT in pulmonary research.  Moreover, when imaging 
the lungs, long scanning times are necessary to include respiratory gating in order to 
avoid motion artifacts due to breathing.  Therefore, x-ray doses and hence the risks 
for radiation-induced lung injury tend to be higher in lung CT studies.  As studies 
assessing radiotoxicity issues when using µCT for longitudinal mouse lung imaging 
are currently lacking, we aimed at evaluating the potential radiotoxicity of repeated 
retrospectively gated lung µCT scans for different long-term imaging protocols and 
validated our results with histochemical techniques to evaluate possible radiotoxicity-
induced lung fibrosis.   
 
Method 
 
We used 48 adult male C57Bl/6 mice of 8 weeks old, kept on food and water ad 
libitum.  The mice were divided in 4 experimental (E1 - E4) and 4 control groups (C1 
- C4) (n = 4 per group) and subjected to different CT imaging schedules as follows:  
- Group E1: µCT 1 x per week during 5 weeks  
- Group E2: µCT 2 x per week during 5 weeks 
- Group E3: µCT 1 x per week during 12 weeks  
- Group E4: µCT 2 x per week during 5 weeks, incl. 1 x high-dose scan in week 3.   
- Group C1: non-scanned controls, 1x CT at 5 weeks 
- Group C2: non-scanned controls, 1x CT at 12 weeks 
- Group C3: age-matched never scanned controls at 5 weeks 
- Group C4: age-matched never scanned controls at 12 weeks. 
 
Retrospectively gated µCT images were acquired on a dedicated small animal µCT 
scanner (SkyScan 1076, Bruker micro-CT) with the following parameters: 50 kV, 0.5 
mm Al filter, 200 µA source current, 35 µm isotropic resolution, 120 ms exposure 
time, 9 projection images per 0.7° rotation step and FOV covering the lung.  For the 
high-dose scan, exposure time - and hence x-ray dose - was tripled to 450 ms.  
Image analysis, segmentation of CT data and quantification of aerated lung volume 
were performed with custom written algorithms using SkyScan software as described 
before [2] with minor modifications.  After the last imaging time point, mice were 
sacrificed, ex vivo CT data were acquired and the lungs were isolated for histological 
analysis and quantification, i.e. scoring of the extent of lung fibrosis by the method of 
Ashcroft on HE-stained lung sections and quantification of the collagen content of the 
lung by hydroxyproline assay as described before [2].  
Radiation dose per scan was measured in two independent ways by introducing an 
ionization chamber in the scanner and by placing thermoluminescent dosimeters 
(TLDs, n = 3) in the scanner while using the above mentioned scanning protocol.  
Lung dose was measured ex vivo by introducing TLDs (n = 3) in the lung of a 
sacrificed mouse, skin dose by placing TLDs (n = 3) on the skin of a mouse.  The 
measurements were repeated three times and reported as mean ± SD.   
 
Results 
 
The average total dose for one retrospectively gated µCT scan as measured by the 
ionization chamber was found to be 1.64 ± 0.04 Gy. This value was used to calibrate 
the TLD measurements, resulting in a measured skin dose of 1104 ± 240 mGy and a 
measured lung dose of 813 ± 103 mGy (Figure 1). 
  
  
 
Figure 1: dosimetry.  Axial and sagittal CT images of a mouse with TLDs at the 
level of the lungs (top row) and of the ionization chamber (bottom row) for measuring 
radiation dose of a scan.    
 
For all experimental groups (E1 – E4), no differences in mean aerated lung volume 
segmented from the CT data compared to the corresponding control mice groups (C1 
– C2) could be found.  Upon visual inspection of the in vivo CT data for individual 
mice, no focal spots of increased density that may correspond to fibrotic areas could 
be identified as compared to controls.  No overt signs of possible other lung injuries 
could be appreciated from the individual in vivo CT images (Figure 2).  Also from ex 
vivo CT images, no signs of lung injury could be appreciated.  Taken together, the 
data indicate that no radiation-induced lung fibrosis could be detected by µCT in the 
current setup.   
To corroborate the µCT data, lung sections will be carefully analyzed and the 
collagen content of lung samples quantified to exclude possible fibrotic lung injuries 
that might not have reached the detection threshold of the µCT.  
 
 
 
Figure 2: CT images and histology.  Axial lung µCT images acquired at 12 weeks 
after baseline and corresponding binary images segmented for aerated lung content 
of a control (left panels) and weekly-scanned mouse (right panels).  In the middle 
panel, an HE-stained histological section showing undamaged lung tissue.   
 
Conclusion 
Despite the relatively large radiation dose that we measured during acquisition of a 
lung µCT scan, mice do not show signs of radiation-induced lung fibrosis that would 
potentially interfere with CT read-out for the lungs when scanned weekly during 5 
and up to 12 weeks.  Doubling the scanning frequency during 5 weeks remained 
without symptoms, indicating that the time resolution of CT scanning can be safely 
increased within the given time frame.   A single tripling of the radiation dose also 
stayed within the limits of the mouse‘s repair capacity and stayed without detectable 
symptoms after 5 weeks of scanning.  This result suggests that, for instance, a failed 
scan can be safely repeated without jeopardizing the experimental outcome.   
To the best of our knowledge, this is the first study assessing potential radiotoxic 
damage during longitudinal µCT scanning, showing that longitudinal monitoring of 
mouse lungs using µCT is safe using the here evaluated imaging protocols.  This 
opens perspectives for the long-term monitoring of lung conditions such as fibrosis, 
emphysema… and therapeutic response on an individual basis with high spatial and 
temporal resolution, without any concerns for radiation toxicity.   
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